Create personalized user journeys with Omnichannel Marketing as a Service.
Leverage a suite of professional services for pharma and life sciences.
Empower your marketing operations with AI and Data.
Develop and enable adaptable pharma and life sciences marketing content.
Adopt a future-proof holistic approach to content strategy.
Enable format-free marketing with content management platform.
The innovation-powered content management platform to produce and distribute high quality digital content
Discover our story, values, and how we're making a positive impact
The Viseven team is about respect, diversity, comfortable working conditions, and equal opportunities for everyone. We explore, evolve, and adapt – together.
Viseven at 4th Annual Pharma AI Summit
October 26 - 27, 2023
London, UK
A closer look at the most significant topics for the sector
It is obvious that pharma cannot neglect the impact of AI.
Viseven is co-sponsoring the event, and Viseven CEO, Nataliya Andreychuk participates in a panel discussion of day 1 of the event:
Crucial Considerations: Navigating the Ethical Terrain of Privacy, Transparency and Regulation
• Ensuring robust data privacy measures while harnessing the power of AI• Addressing ethical concerns regarding patient data collection, consent, and the potential for reidentification in anonymized datasets.• Navigating the evolving regulatory landscape for AI-driven pharmaceutical applications• The role of regulatory agencies in ensuring ethical AI practices
Panelists: Natalya Andreychuk | CEO | VisevenSandeep Mora | Innovation Technology Lead | Boehringer-IngelheimMarco Palladino | Head of Ethical Innovation & Privacy | EUCAN | TakedaMargi Sheth | Director Data Policy | AstraZeneca
Honored to share the stage with colleagues from all over the world! See you on 26.10.2023, 17:30.
Conference Overview 4th Annual Pharma AI Summit
Artificial Intelligence is transforming the pharmaceutical and healthcare sectors, impacting drug discovery, workforce, and patient involvement. The conference will feature industry leaders discussing the potential of AI in improving various processes from drug discovery to clinical trials.
Our Team